Cullinan Therapeutics, Inc. CGEM
Set alert
15.03 USD -0.42 -2.72%
At close
15.87 +0.84 +5.59%
Pre-market · Nov 2, 4:47 AM ET
14.70 Day range 15.72
6.73 52-week range 23.19
- YTD
- +45.22%
- 1 year
- +98.81%
- Open
- 15.38
- Prev close
- 15.45
- Mkt cap
- 967.25M
- Vol
- 389.41K
- Avg vol
- 898.29K
- EPS
- -3.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.70
- High
- 15.72
- Forward P/E
- -6.30
- Beta
- -0.04
- Short ratio
- 6.17
- Inst. own
- 112.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.28
- 200-d avg
- 15.74
- 1y target
- 34.60
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.81; estimate -0.79931; surprise -1.34%
- Sep 14, 2026Rating: BTIG · Buy → Buy
- Sep 25, 2026Rating: BTIG · Buy → Buy
- Sep 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 19, 2026Rating: BTIG · Buy → Buy
- Oct 28, 2026Rating: BTIG · Buy → Buy
Signals (17)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Ownership
Held by insiders 0.43%
Held by institutions 112.54%
Float held by institutions 113.02%
Institutions 256
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MPM Bioimpact LLC | 15.12% | 9,731,341 | 151.42M | Jun 29, 2026 |
| Lynx1 Capital Management Lp | 13.93% | 8,963,500 | 139.47M | Jun 29, 2026 |
| BVF Inc. | 8.94% | 5,750,683 | 89.48M | Jun 29, 2026 |
| Blackrock Inc. | 8.13% | 5,232,766 | 81.42M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.95% | 3,825,950 | 59.53M | Jun 29, 2026 |
| State Street Corporation | 5.70% | 3,668,627 | 57.08M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 1,929,766 | 30.03M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.44% | 1,570,216 | 24.43M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.91% | 1,226,294 | 19.08M | Sep 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.58% | 1,019,356 | 15.86M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.03% | 660,987 | 10.28M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.97% | 621,218 | 9.67M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AHMED NADIM | Chief Executive Officer | Sale | Feb 23, 2026 | 390,803 |
| FENTON MARY KAY | Chief Financial Officer | Stock Award(Grant) | Jun 29, 2026 | 127,921 |
| JONES JEFFREY ALAN | Officer | Sale | Feb 23, 2026 | 159,968 |
| LYNX1 CAPITAL MANAGEMENT LP | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 27, 2025 | 0 |
| MICHAELSON JENNIFER | Officer | Sale | Sep 7, 2026 | 158,844 |
| SAVILL CORRINE | Officer | Stock Award(Grant) | Feb 18, 2025 | 240,990 |
Held by funds
96 US ETFs and mutual funds hold CGEM · largest positions